• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

CD3+、CD4+、CD8+T细胞和CD19+B细胞在急性呼吸窘迫综合征发病中的作用

Effect of CD3+, CD4+, CD8+ T lymphocytes and CD19+ B lymphocytes on the pathogenesis of acute respiratory distress syndrome

摘要:

目的 探讨CD3+、CD4+、CD8+T细胞和CD 19+B细胞在急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)发病中的作用.方法 根据2012年柏林定义的ARDS的诊断标准,人选2016年1月至2017年1月宝鸡市中心医院重症医学科ARDS患者34例作为研究对象(ARDS组),选择同期健康体检者22例为对照组,收集资料并进行跟踪随访.收集确诊ARDS患者第1天的临床资料,根据2012年柏林定义分为中度组(20例)和重度组(14例),随访28 d根据预后情况分存活组(20例)和死亡组(14例).在患者确诊ARDS第1天,清晨空腹抽外周静脉血3 mL,对照组抽空腹外周静脉血3 mL,用流式细胞技术检测患者及和健康对照组血清CD3+、CD4+、CD8+T细胞和CD 19+B细胞水平,将ARDS组与健康对照组的CD3+、CD4+、CD8+T细胞和CD 19+B细胞水平进行比较;将中度组和重度组的CD3+、CD4+、CD8+T细胞和CD 19+B细胞水平进行比较;将存活组和死亡组的CD3+、CD4+、CD8+T细胞和CD19+B细胞水平进行比较;采用多变量logistic回归分析ARDS预后的危险因素,通过ROC曲线分析预后指标.结果 确诊ARDS第1天,存活组和死亡组在乳酸、血清前白蛋白比较,差异有统计学意义(P<0.05);早期ARDS患者外周静脉血清CD3+、CD4+T细胞和CD19+B明显低于健康对照组,差异有统计学意义(P<0.05),CD8+与健康组比较,差异无统计学意义(P>0.05);中度组患者外周静脉血清CD3+、CD4+、CD8+T细胞和CD 19+B水平明显高于重度组,差异有统计学意义(P<0.05);存活组患者CD3+、CD4+、CD8+T细胞和CD19+B细胞水平明显高于死亡组,差异有统计学意义(P<0.05);Logistic回归分析显示,早期CD19+B细胞水平(OR=0.614,95%CI:0.416~0.907,P=0.014)是ARDS预后的危险因素.人院24 h内CD19+B细胞水平ROC曲线下面积为0.907,28 d存活预测最佳临界值为12.59%.结论 早期ARDS患者外周血CD3+、CD4+、CD8+T细胞和CD19+B细胞水平有助于评估ARDS严重程度和预测其预后,CD 19+B细胞更有助于评估ARDS严重程度和预测其预后.

更多
abstracts:

Objective To investigate the roles of CD3+,CD4+,CD8+T lymphocytes and CD19+B lymphocytes on the pathogenesis of acute respiratory distress syndrome(ARDS).Methods According to Berlin definition Of ARDS in 2012,34 patients with ARDS admitted in the Department of ICU of Central Hospital of Baoji from January,2016 to January,2017 were enrolled in this study as study group(ARDS group).At the same time,22 healthy subjects were recruited as control group.Clinical data of ARDS patients were collected,and the survivors were followed up.The ARDS patients were divided into moderate group(n=20) and severe group (n=14) according to clinical settings on the first day after diagnosis of ARDS and Berlin Definition of ARDS in 2012,and at the same time they were also dividedinto two groups according to the outcome followed up for 28 days:non-survival group(n=14) and survival group(n =20).Sample of 3 mL peripheral venous blood of ARDS patients was collected on an empty stomach in the early morning on the first day after diagnosis of ARDS and the blood samples of healthy subjects were also collected on the first day to measure the level of CD3+,CD4+,CD8+T cells and CD19+ B cell in peripheral venous blood by flow cytometry.Comparison of CD3+,CD4+,CD8+ T cells and CD 19+ B cell numbers were carried out between ARDS group and control group on the first day after diagnosis of ARDS,and between moderate group and severe group as well as between survival group and nonsurvival group.The risk factors associated with ARDS were analyzed using logistic regression analysis.Results On the first day after diagnosis of ARDS,there were significant differences in serum Lac and pre-albumin between survival group and non-survival group(P<0.05).The numbers of CD3+,CD4+T cells and CD19+B cell of peripheral venous serum in ARDS group were significantly lower than those in control group(P<0.05),while there was no significant difference in CD8+ T cell number between ARDS group and control group (P>0.05).There were statistically significant differences in numbers of CD3+,CD4+,CD8+T cells and CD19+B cell between moderate group and severe group and as well as between survival group and non-survival group(P<0.05).Logistic regression analysis showed that CD19+B cell (OR=0.614,95%CI:0.416-0.907,P=0.014) level on the first day after diagnosis of ARDS was related with the risk of prognosis of ARDS.The ROC of CD19+B cell had area under curve(AUC) of 0.907,and the cut-off value of CD19+B cell in the survival followed up for 28 day's was 12.59%.Conclusions CD3+,CD4+,CD8+T cells and CD19+B cell level of peripheral venous serum in ARDS patients can be helpful for the assess of ARDS severity of patients in the early stage,and for prognosis judgment,especially CD 19+B cell is more remarkable.

More
  • 浏览:195
  • 下载:105

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷